US 2022/0024967 A1 · SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR

Abstract

The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use

Claims1

Dependent claims

A citrate salt of Compound 1.

Dependencies are inferred from the claim text.

Facts

Application

17/143,602Filed 7 Jan 2021

Priority

31 Aug 2018

Published

27 Jan 2022

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

C07J 43/003
Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopentahydrophenanthrene skeleton: not condensed
A61K 9/20
Medicinal preparations characterised by special physical form: pills, tablets, discs, rods
A61P 25/08
Drugs for disorders of the nervous system: antiepileptics; Anticonvulsants
A61P 25/22
Drugs for disorders of the nervous system: anxiolytics

Family

Application62/725,805Us provisional application · filed 31 Aug 2018

Application16/517,369Continuation · filed 19 Jul 2019

Application16/698,057Continuation · filed 27 Nov 2019

Application17/143,602Continuation

US 10,562,930 B1Related patent

US 10,927,141 B2Related patent

US 2020/0071350 A1Published application

US 2020/0255471 A1Published application

US 2022/0024967 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use

Salts and crystal forms of gaba-a positive allosteric modulator

Life of this patent

Abstract

Claims1

Salts and crystal forms of gaba-a positive allosteric modulator

Life of this patent

Abstract

Claims1